
Clindamycin Injection (Iv/Im) Suppliers & Bulk Manufacturers
Available Forms: Injection (IV/IM)
Available Strengths: 300 mg/2 mL, 600 mg/4 mL
Reference Brands: Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU)
Category: Antibiotics
Clindamycin Injection (IV/IM) is available in Injection (IV/IM) and strengths such as 300 mg/2 mL, 600 mg/4 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Clindamycin Injection (IV/IM) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Clindamycin Injection (IV/IM) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Clindamycin IV/IM is approved in the EU and US for severe bacterial infections, including skin, respiratory, and intra-abdominal infections. In the EU, brands like Cleocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for clindamycin IV/IM, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Cefradine
Strength:
250 mg, 500 mg
Form: Tablets
Reference Brands: Velosef (USA/EU), Intracef (EU)
View DetailsDaptomycin
Strength:
350 mg, 500 mg
Form: Injection
Reference Brands: Cubicin (USA/EU), Dapzura RT (USA)
View DetailsProcaine Penicillin
Strength:
600,000 IU, 1,200,000 IU
Form: Injection
Reference Brands: Farmaproina (EU), Wycillin (USA)
View DetailsIsoniazid + Rifampicin
Strength:
300mg+150mg, 100mg+150mg
Form: Capsules / Tablet
Reference Brands: Rifamate (USA), IsonaRif (USA), Rifinah(UK)
View DetailsQuick Response Guaranteed | Verified Suppliers